Market Value: HUTCHMED (China) Limited (HCM)

HUTCHMED (China) Limited combines Western clinical standards with Eastern scientific ethics, attracting leading researchers through the development of R&D centers. Scaling approved drugs in the PRC is accelerating ARR growth, while this price chart confirms that the market capitalization stands at 2.60. The company generates revenue in the global pharmaceutical market and through partnerships with industry behemoths, helping patients with severe pathologies.

hutch-med.com - HCM Market Capitalization (period 07/04/2022 - 11/14/2026)

HUTCHMED (China) Limited - analytical breakdowns and key metrics (HCM)

- current price and projected stock value:

Stock Price HUTCHMED Corp|HCM - Consensus Target

- company stock exchange capitalization indicators:

Market Value Hutchison MediPharma|HCM - Real Price to Acquire Entire Company

- book value of equity indicators:

Book Value per Share HUTCHMED|HCM - Book Value of Business|Market Capitalization to Book Value Ratio hutch-med.com|HCM - Company Assets

- debt level and financial liquidity data:

- financial results and valuation multiples details:

HCM - Company Net Income|Future Profit HUTCHMED (China) Limited|HCM - Company Value to Net Income|Future Price to Earnings Hutchison MediPharma|HCM - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HUTCHMED Ltd|HCM - Operating profit before amortization|Net earnings per share (EPS TTM) HUTCHMED|HCM - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months hutch-med.com|HCM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year HUTCHMED (China) Limited

- revenue and sales proceeds data:

HCM - Company Revenue|Company Projected Revenue hutch-med.com|HCM - Price to Sales|Forward P/S Multiple HUTCHMED (China) Limited

Initial company analysis:HCM (HUTCHMED Ltd)

Market capitalization determines the total value of a business, calculated as the product of the current share price and the total number of outstanding securities. The price action of the total market value of HUTCHMED (HCM) shares reflects the balance between the risk of a "value trap" and growth potential, which for HUTCHMED (HCM) is supported by strategic partnerships in oncology and the scaling of clinical trials across global markets.

Key competitors